Advancing cell-based cancer immunotherapy through stem cell engineering is a research paper published in Cell stem cell (2023). On theSindex it has a DataRank of 0. It has been cited 84 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
California Institute for Regenerative Medicine
Grant: DISC2-11157
California Institute for Regenerative Medicine
Grant: DISC2-13505
California Institute for Regenerative Medicine
Grant: DISC2COVID19-12020
California Institute for Regenerative Medicine
Grant: TRAN1-08533
California Institute for Regenerative Medicine
Grant: TRAN1-12250
National Institutes of Health
Grant: DP2 CA196335
NCI NIH HHS
Grant: P30 CA016042
National Institutes of Health
Grant: 1DP2CA196335-01
Stem Cell-Engineered Invariant Natural Killer T Cells for Cancer Therapy
University of California, Los Angeles
USC
The Rose Hills Foundation
Concern Foundation
STOP CANCER
FWCI
9.77
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals